Mainly, cyanidin‐3‐O‐glucoside suppresses inflammation and the production of pro‐inflammatory cytokines (COX‐2, TNF‐α, and IL‐6) in colorectal and hepatocellular carcinoma and causes cell cycle inhibition and mitochondrial dysfunction in ovarian and cervical malignancies. Here, TNF is linked to hepatocellular carcinoma.